ReviewPsychology research and behavior management2020
Spotlight on the Fear of Cancer Recurrence Inventory (FCRI).
Review in Psychology research and behavior management, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 58 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial
Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene
Who cites it
58 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Guideline
- A systematic mixed studies review of fear of cancer recurrence in families and caregivers of adults diagnosed with cancer.Journal of cancer survivorship : research and practice · 2022Pooled it
- What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis.Psycho-oncology · 2022Pooled it
- Long-Term Outcomes, Moderators, and Predictors in Online Mindfulness-Based Cognitive Therapy for People With Cancer: Secondary Analysis of a Randomized Controlled Trial.Journal of medical Internet research · 2026Trial
- Fear of Cancer Recurrence and Psychological Symptom Burden in Breast Cancer Survivors Without Evidence of Active Disease: A Cross-Sectional Real-World Study.Healthcare (Basel, Switzerland) · 2026Article
- Psilocybin for Fear of Cancer Recurrence.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Fear of cancer recurrence among cancer survivors in South Korea: high prevalence and predictors of clinical FCR.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Fear of cancer recurrence in papillary thyroid cancer: a comparison across ATA risk groups and influencing factors.Endocrine · 2026Article
- Introducing the Ottawa Clinical Fear of Recurrence-Self-Report; A New Assessment Tool for Clinical Fear of Cancer Recurrence.Psycho-oncology · 2026Article
- Overlap and distinction between fear of cancer recurrence and health anxiety in long-term colorectal cancer survivors.Journal of cancer survivorship : research and practice · 2026Article
- Fear of cancer recurrence and assessing its relationship with cognitive flexibility and coping strategies: a cross-sectional study.BMC psychology · 2026Article
- Validation of the fear of cancer recurrence inventory-short form in long-term colorectal cancer survivors.Journal of patient-reported outcomes · 2026Article
- Validation of the Czech version of the nine-item Fear of Cancer Recurrence Inventory in differentiated thyroid cancer survivors.Endocrine · 2026Article
- Article
- Predictive Relationships Between Death Anxiety and Fear of Cancer Recurrence in Patients with Breast Cancer: A Cross-Lagged Panel Network Analysis.Current oncology (Toronto, Ont.) · 2025Article
- Fear of cancer recurrence and perceived pain in patients with breast cancer: A network analysis approach.Asia-Pacific journal of oncology nursing · 2025Article
- Fear and Medical Misinformation Regarding Risk of Progression or Recurrence Among Patients with Breast Cancer.JAMA network open · 2025Article
- Fear of cancer recurrence in long-term post-menopausal breast cancer women: evidence from the French national VICAN survey.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- Assessment of Fear of Cancer Recurrence in Patients with Colorectal Cancer and Its Association with Pet Ownership: A Cross-Sectional Study.Current oncology (Toronto, Ont.) · 2025Article
- Efficacy of an online mindfulness program (EClinicalMedicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fear of cancer recurrence (FCR) is a pervasive concern for people living with cancer. The rapidly expanding FCR literature has been weakened somewhat by use of miscellaneous FCR measures of varying quality. The Fear of Cancer Recurrence Inventory (FCRI) has been widely used in observational and intervention studies and the FCRI severity subscale, also known as the FCRI-Short Form (FCRI-SF), is often used to identify potential cases of clinically significant FCR. Given the FCRI's increasing use in research and clinical practice, we aimed to provide an overview, critique, and suggested improvements of the FCRI. Studies citing the original FCRI validation paper were identified and synthesised using narrative and meta-analytic methods. The 42-item FCRI has demonstrated a reasonably robust 7-factor structure across evaluations in multiple languages, although certain subscales (eg, Coping) demonstrate sub-optimal reliability. Confirmation of the cross-cultural equivalence of several FCRI translations is needed. Meta-analysis of FCRI-SF scores revealed a combined weighted mean score of 15.7/36, a little above the lowest proposed cut-off score (≥13) for clinical FCR. Depending on the FCRI-SF cut-off used, between 30.0% and 53.9% of the cancer population (ie, patients and survivors) appear to experience sub-clinical or clinical FCR. Higher FCRI scores were associated with younger age and female gender, pain/physical symptoms and psychological morbidity, consistent with the FCR literature generally. Issues regarding the application and interpretation of the FCRI remain. Whether the FCRI is well suited to assessing fear of progression as well as recurrence is unclear, the meaningfulness of the FCRI total score is debatable, and the use of the FCRI-SF to screen for clinical FCR is problematic, as items do not reflect established characteristics of clinical FCR. Refinement of the FCRI is needed for it to remain a key FCR assessment tool in future research and clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.